6PC
PYRIDINE-2-CARBOXYLIC ACID
Created: | 2006-05-23 |
Last modified: | 2020-06-05 |
Find Related PDB Entry |
---|
Find related ligands: |
---|
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 14 |
Chiral Atom Count | 0 |
Bond Count | 14 |
Aromatic Bond Count | 6 |
Chemical Component Summary | |
---|---|
Name | PYRIDINE-2-CARBOXYLIC ACID |
Synonyms | PICOLINIC ACID |
Systematic Name (OpenEye OEToolkits) | pyridine-2-carboxylic acid |
Formula | C6 H5 N O2 |
Molecular Weight | 123.109 |
Type | NON-POLYMER |
Chemical Descriptors | |||
---|---|---|---|
Type | Program | Version | Descriptor |
SMILES | ACDLabs | 10.04 | O=C(O)c1ncccc1 |
SMILES | CACTVS | 3.341 | OC(=O)c1ccccn1 |
SMILES | OpenEye OEToolkits | 1.5.0 | c1ccnc(c1)C(=O)O |
Canonical SMILES | CACTVS | 3.341 | OC(=O)c1ccccn1 |
Canonical SMILES | OpenEye OEToolkits | 1.5.0 | c1ccnc(c1)C(=O)O |
InChI | InChI | 1.03 | InChI=1S/C6H5NO2/c8-6(9)5-3-1-2-4-7-5/h1-4H,(H,8,9) |
InChIKey | InChI | 1.03 | SIOXPEMLGUPBBT-UHFFFAOYSA-N |
Drug Info: DrugBank
DrugBank ID | DB05483 |
---|---|
Name | Picolinic acid |
Groups | investigational |
Description | PCL-016 or Picolinic acid drug substance is a pyridine carboxylate metabolite of tryptophan. It acts as an anti-infective and immunomodulator and is produced in approximately 25-50 mg quantities by the body on a daily basis through the breakdown of tryptophan. PCL-016 plays a key role in zinc transport. As a therapeutic agent, the molecule works by binding to zinc finger proteins (ZFPs) in a way that changes their structures and disrupts zinc binding, inhibiting function. ZFPs are involved in viral replication and packaging as well as normal cell homeostatic functions. Picolinic acid has been shown to be an anti-viral in vitro and in vivo, and sometimes works in conjunction with other cytokines such as interferon gamma to affect immune responses. Acne vulgaris, herpes and other viral infections therefore pose potential therapeutic targets of PCL-016. |
Synonyms |
|
Indication | Investigated for use/treatment in acne, herpes labialis infections (cold sores), and venereal disease. |
Categories |
|
CAS number | 98-98-6 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
E3 ubiquitin-protein ligase UBR4 | MATSGGEEAAAAAPAPGTPATGADTTPGWEVAVRPLLSASYSAFEMKELP... | unknown | |
Zinc finger Y-chromosomal protein | MDEDEFELQPQEPNSFFDGIGADATHMDGDQIVVEIQEAVFVSNIVDSDI... | unknown |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL72628 |
PubChem | 1018 |
ChEMBL | CHEMBL72628 |
ChEBI | CHEBI:28747 |
CCDC/CSD | UBUFIJ, PAQMIG, MOMVIV01, MOMVIV, NAFZAY |